Summary
To know the potential of growth, invasion and metastasis of uterine cervical cancer associated with neovascularization, localization of vascular endothelial growth factor (VEGF) and microvessel density in tumours were determined by immunohistochemical staining, the levels of VEGF subtypes were determined by Western blot analysis and by a sandwich enzyme immunoassay, and the levels of VEGF subtype mRNAs were determined by reverse transcription polymerase chain reaction (RT-PCR) – Southern blot analysis in uterine cervical cancers. The relation between VEGF subtype expressions and microvessel density, histological types and clinical stages of uterine cervical cancers was analysed. The expression of VEGF was seen dominantly in the cancer cells, and correlated with microvessel density in uterine cervical cancers. Among the four subtypes of VEGF, the populations of VEGF165 and VEGF121 were dominant in normal uterine cervices and uterine cervical cancers. The levels of VEGF and VEGF165 and VEGF121 mRNAs were remarkably higher in some stage II and III/IV adenocarcinomas of the cervix than in other cases, including normal cervices. Therefore, the elevation of VEGF165 and VEGF121 might contribute to the relatively late advancing via angiogenic activity in some adenocarcinomas of the cervix.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Arcari, P., Martinelli, R. & Salvatore, F. (1984). The complete sequences of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 12: 9179–9189.
Berkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., Robertson, J. T., Ali, I. U. & Oldfield, E. H. (1993). Expression of vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91: 153–159.
Bradford, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 315–323.
Cheng, S. Y., Nagane, M., Huang, H. S. & Cavenee, W. K. (1997). Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc Natl Acad Sci USA 94: 12081–12087.
Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate–phenol–chloroform extraction. Anal Biochem 162: 156–159.
Denekamp, J. (1984). Vascular as a target for tumor therapy. Prog ApplMicrocirc 4: 28–38.
Dobbs, S. P., Hewett, P. W., Johnson, I. R., Carmichael, J. & Murray, J. C. (1997). Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer 76: 1410–1415.
FIGO, News (1989). Int J Gynecol Obstet 28: 189–193
Folkman, J. (1985). Tumor angiogenesis. Adv Cancer Res 43: 175–203.
Folkman, J. & Haudenschild, C. (1980). Angiogenesis in vitro. Nature 288: 551–556.
Folkman, J. & Ingber, D. E. (1987). Angiostatic steroids. Ann Surg 206: 374–383.
Fujimoto, J., Hosoda, S., Fujita, H. & Okada, H. (1989). Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invasion Metastasis 9: 269–277.
Fujimoto, J., Ichigo, S., Hori, M., Hirose, R., Sakaguchi, H. & Tamaya, T. (1997). Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers. Cancer Lett 111: 21–26.
Fujimoto, J., Sakaguchi, H., Hirose, R., Ichigo, S. & Tamaya, T. (1998a). Biological implication of the expression of vascular endothelial growth factor in ovarian cancers. Cancer 83: 2528–2533.
Fujimoto, J., Sakaguchi, H., Hirose, R. & Tamaya, T. (1998b). Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers. Cancer Lett 134: 15–22.
Fujimoto, J., Ichigo, S., Sakaguchi, H., Hirose, R. & Tamaya, T. (1999). Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers. Br J Cancer 79: 1249–1254.
Garrido, C., Saule, S. & Gospodarowicz, D. (1993). Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factor 8: 109–117.
Guidi, A. J., Abu-Jawdeh, G., Berse, B., Jackman, R. W., Tognazzi, K., Dvorak, H. F. & Brown, L. F. (1995). Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 87: 1237–1245.
Guidi, A. J., Abu-Jawdeh, G., Tognazzi, K., Dvorak, H. F. & Brown, L. F. (1996). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial cancers. Cancer 78: 454–460.
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., LI, B. & Leung, D. W. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 12: 1806–1814.
Ingber, D., Fijita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. & Folkman, J. (1990). Synthetic analog of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555–557.
Jackson, M. R., Carney, E. W., Lye, S. J. & Knoxritchie, J. W. (1994). Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 15: 341–353.
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J. & Connolly, D. T. (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309–1312.
Leung, D. W., Cachianes, G., Kuang, W-J, Goeddel, D. V. & Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306–1309.
Li, X. F., Gregory, J. & Ahmed, A. (1994). Immunolocalization of vascular endothelial growth factor in human endometrium. Growth Factors 11: 277–282.
Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F. & Angeletti, G. A. (1992). Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340: 145–146.
Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., Onoda, N., Kato, Y. & Sowa, M. (1996). Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884–888.
Olson, T. A., Mohanraj, D., Carson, L. F. & Ramakrishnan, S. (1994). Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 54: 276–280.
Oshika, Y., Nakamura, M., Tokunaga, T., Ozeki, Y., Fukushima, Y., Hatanaka, H., Abe, Y., Yamazaki, H., Kijima, H., Tamaoki, N. & Ueyama, Y. (1998). Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int J Oncol 12: 541–544.
Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E. & Neufeld, G. (1997). VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 272: 7151–7158.
Scott, P. A., Smith, K., Poulsom, R., DE Benedetti, A., Bicknell, R. & Harris, A. L. (1998). Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF–4E. Br J Cancer 77: 2120–2128.
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. & Dvorak, H. S. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983–985.
Srivastava, A., Laidler, P., Davies, R. P., Horgan, K. & Hughes, L. (1988). The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma. Am J Pathol 133: 419–423.
Tokumo, K., Kodama, J., Seki, N., Nakanishi, Y., Miyagi, Y., Kaminuma, S., Yoshinouchi, M., Okuda, H. & Kudo, T. (1998). Different angiogenic pathways in human cervical cancers. Gynecol Oncol 68: 38–44.
Tokunaga, T., Oshika, Y., Abe, Y., Ozeki, Y., Sadahiro, S., Kijima, H., Tsucida, T., Yamazaki, H., Ueyama, Y., Tamaoki, N. & Nakamura, M. (1998). Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77: 998–1002.
Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., Asano, K., Tokuda, T., Aizawa, S. & Ushigome, S. (1992). Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 168: 257–262.
Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A. & Ferrara, N. (1995). Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse of experimental liver metastasis. J Clin Invest 95: 1789–1797.
Weidner, N., Semple, J. P., Welch, W. R. & Folkman, J. (1991). Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324: 1–7.
Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W. & Folkman, J. (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401–409.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Fujimoto, J., Sakaguchi, H., Hirose, R. et al. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers. Br J Cancer 80, 827–833 (1999). https://doi.org/10.1038/sj.bjc.6690428
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690428
Keywords
This article is cited by
-
Serum vascular endothelial growth factor: a prognostic factor in cervical cancer
Journal of Cancer Research and Clinical Oncology (2009)
-
Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers
British Journal of Cancer (2008)
-
Novel therapeutic strategy for uterine endometrial cancers
International Journal of Clinical Oncology (2008)
-
The association of smoking, alcoholic consumption, betel quid chewing and oral cavity cancer: a cohort study
European Archives of Oto-Rhino-Laryngology (2008)
-
Expression of IP-10 related to angiogenesis in uterine cervical cancers
British Journal of Cancer (2007)
